What's New

Last Posted: Mar 21, 2023

• Convolutional Neural Network Quantification of Gleason Pattern 4 and Association with Biochemical Recurrence in Intermediate Grade Prostate Tumors.
  Yalei Chen et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 100157
• Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
  Michael Baboudjian et al. World journal of urology 2023
• Are population level familial risks and germline genetics meeting each other?
  Kari Hemminki et al. Hereditary cancer in clinical practice 2023 21(1) 3
• Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
  Lauren G Santos et al. JAMA network open 2023 6(3) e231723
• The role of community health advisors' cancer history in implementation and efficacy of a cancer control intervention.
  Maisha R Huq et al. Health education research 2023
• Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
  Shaoxu Wu et al. The Lancet. Oncology 2023
• Label Distribution Learning for Automatic Cancer Grading of Histopathological Images of Prostate Cancer.
  Mizuho Nishio et al. Cancers 2023 15(5)
• A Polygenic Risk Score for Prostate Cancer Risk Prediction.
  Kerry R Schaffer et al. JAMA internal medicine 2023 3
• Bringing Prostate Cancer Polygenic Risk Scores to the Clinic.
  Robert J Klein et al. JAMA internal medicine 2023 3
• Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.
  Ali Sabbagh et al. European urology oncology 2023
• Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer.
  Hajar Hasannejadasl et al. PloS one 2023 18(3) e0276815
• Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
  Zhaonan Sun et al. Journal of magnetic resonance imaging : JMRI 2023
• Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer.
  Timothy N Chu et al. Current urology reports 2023
• Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer.
  Maibritt Nørgaard et al. Clinical chemistry 2023
• Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning.
  Ping Xie et al. Frontiers in oncology 2023 121084403
• Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at high genetic risk.
  Cussenot Olivier et al. BJU international 2023
• Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment.
  Oh Mok et al. Expert review of pharmacoeconomics & outcomes research 2023
• Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer.
  Kwon Daniel H et al. JCO oncology practice 2023 OP2200638
• Usefulness of podcasts to provide public education on prostate cancer genetics.
  Loeb Stacy et al. Prostate cancer and prostatic diseases 2023
• The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer.
  Fang Bangwei et al. Journal of clinical medicine 2023 12(2)

More